TH65849A - Drug precursor -3 'of 2'-deoxy-beta-L-nucleoside - Google Patents
Drug precursor -3 'of 2'-deoxy-beta-L-nucleosideInfo
- Publication number
- TH65849A TH65849A TH101002334A TH0101002334A TH65849A TH 65849 A TH65849 A TH 65849A TH 101002334 A TH101002334 A TH 101002334A TH 0101002334 A TH0101002334 A TH 0101002334A TH 65849 A TH65849 A TH 65849A
- Authority
- TH
- Thailand
- Prior art keywords
- nucleoside
- beta
- deoxy
- hepatitis
- drug precursor
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract 4
- 229940079593 drug Drugs 0.000 title claims abstract 4
- 239000002777 nucleoside Substances 0.000 title claims abstract 4
- 239000002243 precursor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000001177 diphosphate Substances 0.000 claims 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims 1
- 235000011180 diphosphates Nutrition 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 150000004712 monophosphates Chemical class 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000001226 triphosphate Substances 0.000 claims 1
- 235000011178 triphosphate Nutrition 0.000 claims 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 abstract 2
- 208000002672 hepatitis B Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
Abstract
DC60 (11/09/44) การประดิษฐ์นี้เกี่ยวข้องกับสารผสมและวิธีสำหรับการรักษาเจ้าบ้านที่ได้รับเชื้อไวรัสก่อโรค ตับอักเสบ B โดยเฉพาะสารผสมของ 3'-เอสเทอร์ของ 2'-ดีออกซี-เบตา-L-นิวคลีโอไซด์ได้ถูกเปิดเผยไว้ ซึ่งสามารถถูกให้เพียงอย่างเดียวหรือในการรวมกับยาต้านตับอักเสบ B อื่นๆ การประดิษฐ์นี้เกี่ยวข้องกับสารผสมและวิธีสำหรับการรักษาเจ้าบ้านที่ได้รับเชื้อไวรัสก่อโรค ตับอักเสบ B โดยเฉพาะสารผสมของ 3'-เอสเทอร์ของ 2'-ดีออกซี-เบตา-L-นิวคลีโอไซด์ได้ถูกเปิดเผยไว้ ซึ่งสามารถถูกให้เพียงอย่างเดียวหรือในการรวมกับยาต้านตับอักเสบ B อื่นๆ สิทธิบัตรยา DC60 (11/09/44) This invention involves a mixture and a method for the treatment of hosts specifically exposed to the hepatitis B virus. 3'-esters 2'-Deoxy-Beta-L-Nucleoside has been revealed. This can be administered alone or in combination with other anti-hepatitis B drugs. The invention involves mixtures and methods for treating hosts specifically infected with hepatitis B virus. 3'-esters 2'-Deoxy-Beta-L-Nucleoside has been revealed. It can be given alone or in combination with other anti-hepatitis B drugs.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH65849A true TH65849A (en) | 2004-12-27 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005007681A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| DK1257281T3 (en) | Nucleoside analogs with carboxamidine-modified monocyclic base | |
| ATE313550T1 (en) | BETA-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B VIRUS | |
| NO20075042L (en) | Pharmaceutical composition including an omega-carboxyaryl-substituted diphenylurea for the treatment of cancer | |
| EA200200778A1 (en) | METHOD OF TREATMENT OR PREVENTION OF HEPATITIS C INFECTION IN THE ORGANISM ORGANISM, PHARMACEUTICAL COMPOSITION AGAINST FLAVIVIRUS, CONNECTION OF FORMULA Ib - AN ACTIVE AGENT FOR THE TREATMENT OR PREVENTION OF EFFECTECH EFFECTURES Ib - AN ACTIVE AGENT FOR THE TREATMENT OR PREVENTION INEKEKHEKUSA Ib - AN ACTIVE AGENT FOR THE TREATMENT OR PROTECTION | |
| DE602004023924D1 (en) | Ease-hemmer | |
| MY128463A (en) | 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
| WO2005037860A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| PT1404347E (en) | 4'-SUBSTITUTED NUCLEOSID FOR THE TREATMENT OF DISEASES MEDIATED BY HEPATITIS C VIRUS | |
| NO20052130L (en) | Strong inhibitor of HCV serine protease | |
| WO2005077969A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| DE60217114D1 (en) | BROKEN BICYCLIC SERINE PROTEASE INHIBITORS | |
| DE60234577D1 (en) | PHARMACEUTICAL MIXTURE FOR THE TREATMENT OF CANCER CONTAINING DIOXOLANE NUCLEOSIDE ANALOGUE | |
| EA200600227A1 (en) | SUBSTITUTED ARILTIOMAURS APPLICABLE AS AN INHIBITOR VIRUS REPLICATION | |
| NZ510811A (en) | Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection | |
| CN102775458B (en) | The preparation of β-D-(2 ' R)-2 '-deoxidation-2 '-fluoro-2'CmeC derivative and purposes | |
| BR0107912A (en) | Compound, compositions, and, methods for treating or preventing cancer or neoplastic disease, method for inhibiting the development of a cancer cell or neoplastic cell, method for treating or preventing viral infection in a patient, and for inhibiting replication or infectivity of a virus | |
| TH65849A (en) | Drug precursor -3 'of 2'-deoxy-beta-L-nucleoside | |
| CN108003212A (en) | A kind of dehydroepiandros-sterone -6- glucoside derivatives and its application as anti hepatitis C virus drug | |
| ATE301997T1 (en) | ANTIVIRAL THERAPY | |
| JP2005519919A5 (en) | ||
| TH117334A (en) | Compounds for the treatment of hepatitis C | |
| ATE270886T1 (en) | ANTIVIRAL THERAPY | |
| TH52792A3 (en) | Combination therapy of ribavirine-interferon alpha to destroy detectable HCV-RNA in patients with chronic hepatitis C infection. | |
| BR0016844A (en) | Treatment of drug-resistant human immunodeficiency virus infection |